Indefinite Delivery Contract SPE2DX15D9764

The Defense Logistics Agency (DLA) awarded a $499,999,999 single-award Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The IDC, valid through November 2026, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide. The contract does not have any set-aside designations, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains.

Under the IDC, the DLA has issued numerous delivery orders to DMS Pharmaceutical Group for the supply of a variety of pharmaceutical products, such as Primaquine, Metronidazole, Forane Liquid, Sulfamethoxazole-TMP DS Tablets, Keppra, Rocuronium, Acetaminophen, and others. These delivery orders range in value from a few dollars to over $10,000, with the largest single award valued at $6,326.74. The contracted items are intended to support the medical supply needs of Department of Defense healthcare facilities, positioning DMS Pharmaceutical Group as a critical supplier in the federal pharmaceutical supply chain.